Evidence map›Paper›PMID 37733153›Full record

ArticleMedical & biological engineering & computing2024

Microfluidic design for in-vitro liver zonation-a numerical analysis using COMSOL Multiphysics.

Reza Mahdavi, Sameereh Hashemi-Najafabadi, Mohammad Adel Ghiass, Caroline Beck Adiels

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reza MahdaviBiotechnology Department, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, P.O. Box 14115-114, Iran.
Sameereh Hashemi-NajafabadiBiomedical Engineering Department, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, P.O. Box 14115-114, Iran. s.hashemi@modares.ac.ir.
Mohammad Adel GhiassTissue Engineering Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, P.O. Box 14115-114, Iran.
Caroline Beck AdielsDepartment of Physics, University of Gothenburg, 41296, Gothenburg, Sweden. caroline.adiels@physics.gu.se.

Funding

Swedish Foundation for Strategic Research ITM17-0384
6 · The paper itself

Abstract

The liver is one of the most important organs, with a complex physiology. Current in-vitro approaches are not accurate for disease modeling and drug toxicity research. One of those features is liver zonation, where cells display different physiological states due to different levels of oxygen and nutrient supplements. Organ-on-a-chip technology employs microfluidic platforms that enable a controlled environment for in-vitro cell culture. In this study, we propose a microfluidic design embedding a gas channel (of ambient air), creating an oxygen gradient. We numerically simulate different flow rates and cell densities with the COMSOL Multiphysics package considering cell-specific consumption rates of oxygen and glucose. We establish the cell density and flow rate for optimum oxygen and glucose distribution in the cell culture chamber. Furthermore, we show that a physiologically relevant concentration of oxygen and glucose in the chip is reached after 24 h and 30 min, respectively. The proposed microfluidic design and optimal parameters we identify in this paper provide a tool for in-vitro liver zonation studies. However, the microfluidic design is not exclusively for liver cell experiments but is foreseen to be applicable in cell studies where different gas concentration gradients are critical, e.g., studying hypoxia or toxic gas impact.

Indexed as

LiverMicrofluidicsCell Culture TechniquesGlucoseLab-On-A-Chip DevicesOxygenGlucoseOxygenCOMSOLLiver zonationMicrofluidicsNumerical simulationOrgan-on-a-chip

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.